Related references
Note: Only part of the references are listed.In vitro colonisation of the distal colon by Akkermansia muciniphila is largely mucin and pH dependent
F. Van Herreweghen et al.
BENEFICIAL MICROBES (2017)
Mucin secreting cells in the stomach and colon are altered by combination antiretroviral treatment in an obese rat model
Danelle Truter et al.
ACTA HISTOCHEMICA (2017)
MASCC/ISOO Clinical Practice Guidelines for the Management of Mucositis Secondary to Cancer Therapy
Rajesh V. Lalla et al.
CANCER (2014)
Chemotherapy-induced mucositis: The role of mucin secretion and regulation, and the enteric nervous system
Daniel Thorpe et al.
NEUROTOXICOLOGY (2013)
Systematic review of agents for the management of gastrointestinal mucositis in cancer patients
Rachel J. Gibson et al.
SUPPORTIVE CARE IN CANCER (2013)
Emerging evidence on the pathobiology of mucositis
Noor Al-Dasooqi et al.
SUPPORTIVE CARE IN CANCER (2013)
IL-22 Mediates Goblet Cell Hyperplasia and Worm Expulsion in Intestinal Helminth Infection
Jan-Eric Turner et al.
PLOS PATHOGENS (2013)
The enteric nervous system and neurogastroenterology
John B. Furness
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Serum levels of NF-κB and pro-inflammatory cytokines following administration of mucotoxic drugs
Richard M Logan et al.
CANCER BIOLOGY & THERAPY (2010)
Histology and Mucin Histochemistry of The Digestive Tract of Yellow Catfish, Pelteobagrus fulvidraco
X. J. Cao et al.
ANATOMIA HISTOLOGIA EMBRYOLOGIA (2009)
Irinotecan-induced mucositis is associated with changes in intestinal mucins
Andrea M. Stringer et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Gastrointestinal Microflora and Mucins May Play a Critical Role in the Development of 5-Fluorouracil-Induced Gastrointestinal Mucositis
Andrea M. Stringer et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2009)
Irinotecan-induced mucositis manifesting as diarrhoea corresponds with an amended intestinal flora and mucin profile
Andrea M. Stringer et al.
INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY (2009)
Nitrosation of N-methylhydroxylamine by nitroprusside. A kinetic and mechanistic study
Maria Marta Gutierrez et al.
DALTON TRANSACTIONS (2008)
Changes in the mucus barrier of the rat during 5-fluorouracil-induced gastrointestinal mucositis
Yoichi Saegusa et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2008)
Characterisation of mucosal changes in the alimentary tract following administration of irinotecan: implications for the pathobiology of mucositis
Richard M. Logan et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2008)
Risk, outcomes, and costs of radiation-induced oral mucositis among patients with head-and-neck malignancies
Linda S. Elting et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2007)
Irinotecan changes gene expression in the small intestine of the rat with breast cancer
Joanne M. Bowen et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2007)
Methotrexate-induced mucositis in mucin 2-deficient mice
Barbara A. E. De Koning et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2007)
Updated clinical practice guidelines for the prevention and treatment of mucositis
Dorothy M. Keefe et al.
CANCER (2007)
Optimal antidiarrhea treatment for antitumor agent irinotecan hydrochloride (CPT-11)-induced delayed diarrhea
K. Takasuna et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Palifermin reduces diarrhea and increases survival following Irinotecan treatment in tumor-bearing DA rats
RJ Gibson et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Cytotoxic chemotherapy upregulates pro-apoptotic Bax and Bak in the small intestine of rats and humans
JM Bowen et al.
PATHOLOGY (2005)
Perspectives on cancer therapy-induced mucosal injury - Pathogenesis, measurement, epidemiology, and consequences for patients
ST Sonis et al.
CANCER (2004)
Gastrointestinal mucositis: a new biological model
DMK Keefe
SUPPORTIVE CARE IN CANCER (2004)
Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis
EB Rubenstein et al.
CANCER (2004)
The burdens of cancer therapy - Clinical and economic outcomes of chemotherapy-induced mucositis
LS Elting et al.
CANCER (2003)
Irinotecan causes severe small intestinal damage, as well as colonic damage, in the rat with implanted breast cancer
RJ Gibson et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2003)
Effect of interleukin-11 on ameliorating intestinal damage after methotrexate treatment of breast cancer in rats
RJ Gibson et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
The effect of keratinocyte growth factor on tumour growth and small intestinal mucositis after chemotherapy in the rat with breast cancer
RJ Gibson et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2002)
Selective sparing of goblet cells and Paneth cells in the intestine of methotrexate-treated rats
M Verburg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2000)
Chemotherapy for cancer causes apoptosis that precedes hypoplasia in crypts of the small intestine in humans
DMK Keefe et al.
GUT (2000)
Mucin secretion is modulated by luminal factors in the isolated vascularly perfused rat colon
A Barcelo et al.
GUT (2000)
Share Paper
